Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Demyelinating Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01396343
What this trial is testing

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

Who this might be right for
Pediatric Multiple Sclerosis
University of California, San Francisco 1,276
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Not applicableStudy completedNCT04387110
What this trial is testing

Ocrelizumab in Breastmilk

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
University of California, San Francisco 30
Not applicableStudy completedNCT06526000
What this trial is testing

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing-remitting Multiple Sclerosis+1 more
Novartis 326
Not applicableStudy completedNCT03438357
What this trial is testing

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Centre Hospitalier Universitaire de Nīmes 200
Not applicableStudy completedNCT00704834
What this trial is testing

Gene Expression Profiles in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
University of California, Davis 46
Not applicableEnrolling By InvitationNCT07032246
What this trial is testing

Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study

Who this might be right for
Multiple SclerosisRadiologically Isolated SyndromeClinically Isolated Syndrome
icometrix 750
Large-scale testing (Phase 3)Study completedNCT00725985
What this trial is testing

Oral Cladribine in Early Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 617
Not applicableStudy completedNCT02504840
What this trial is testing

Natural History of Multiple Sclerosis and Its Mimickers

Who this might be right for
Neurologic DisordersHealthy VolunteersMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 104
Not applicableActive Not RecruitingNCT04009005
What this trial is testing

Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
Terry L. Wahls 44
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Early research (Phase 1)Study completedNCT00616733
What this trial is testing

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Daiichi Sankyo 25
Not applicableEnded earlyNCT03926637
What this trial is testing

Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 3,073
Not applicableStudy completedNCT02549703
What this trial is testing

Mitochondrial Dysfunction and Disease Progression

Who this might be right for
Clinically Isolated SyndromeRelapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more
Icahn School of Medicine at Mount Sinai 47
Large-scale testing (Phase 3)Study completedNCT00666887
What this trial is testing

Minocycline in Clinically Isolated Syndromes (CIS)

Who this might be right for
Clinically Isolated SyndromesEarly Single Relapse of Multiple Sclerosis
Dr. Luanne Metz 142
Not applicableStudy completedNCT02671682
What this trial is testing

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Albert Christian Ludolph, Prof. 61
Not applicableStudy completedNCT04705610
What this trial is testing

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis (MS) Relapsing RemittingMultiple Sclerosis (MS) Primary Progressive+4 more
Association de Recherche Bibliographique pour les Neurosciences 76
Not applicableUnknownNCT01371071
What this trial is testing

Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, MSClinically Isolated Syndrome
Charite University, Berlin, Germany 200
Large-scale testing (Phase 3)Study completedNCT00666224
What this trial is testing

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 481
Post-approval studies (Phase 4)Study completedNCT04998851
What this trial is testing

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Hoffmann-La Roche 26
Next Page